James Still

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

Aleena Banerji, Paula J. Busse, Mustafa M. Shennak et al. · New England Journal of Medicine · 2017 · 167 citations · Full text

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin

Mark E. Astiz, Eric C. Rackow, James Still et al. · Critical Care Medicine · 1995 · 131 citations

Control of Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With Type 2 Diabetes

Mark Kipnes, Paresh Dandona, Devjit Tripathy et al. · Diabetes Care · 2003 · 96 citations · Full text

Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2

Stephen Clement, James Still, Gordana Kosutic et al. · Diabetes Technology & Therapeutics · 2002 · 84 citations

Metabolic Syndrome, Type 1, Diabetes Management +14

Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial

Stephen Clement, Paresh Dandona, James Still et al. · Metabolism · 2003 · 72 citations

Metabolic Syndrome, Translational Medicine, Type 1 +8